The Gist Healthcare Podcast cover image

Thursday, March 16, 2023

The Gist Healthcare Podcast

00:00

COVID-19 - Is PAC Safe?

The FDA says Pfizer's anti-viral drug, PAC, is safe and can help high-risk individuals with mild to moderate cases of COVID-19 avoid more severe infections. The report also noted that the drug does not cause a so-called rebound infection of CO VID-19. There have been many anecdotal reports that infections were more likely to come back for individuals after taking the five-day course of PAC's COVID. According to data from the Department of Health and Human Services, more than 8.5 million people have received PAC's COvid.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app